Hypericum perforatum extract in burning mouth syndrome: A randomized placebo-controlled study

Journal of Oral Pathology and Medicine

Volumn 37, Issue 7, 2008, Pages 395-401

  Sardella, Andrea ^a,b   Lodi, Giovanni ^a   Demarosi, Federica ^a   Tarozzi, Marco ^a   Canegallo, Lorenza ^a   Carrassi, Antonio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Clinica Odontoiatrica   (Italy)

Author keywords

Burning mouth syndrome; Hypericum extracts; Orofacial pain; Placebo controlled study; Stomatodynia

Indexed keywords

HYPERICUM PERFORATUM EXTRACT; PLACEBO; ANTIDEPRESSANT AGENT; BICYCLO COMPOUND; DRUG DERIVATIVE; HYPERFORIN; HYPERICIN; PERYLENE; PHLOROGLUCINOL; PLANT EXTRACT; TERPENE;

ADULT; ARTICLE; BURNING MOUTH SYNDROME; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; MALE; MOUTH PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE; AGED; HYPERICUM; MIDDLE AGED; NONPARAMETRIC TEST; PHYTOTHERAPY;

AGED; ANTIDEPRESSIVE AGENTS; BICYCLO COMPOUNDS; BURNING MOUTH SYNDROME; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERICUM; MALE; MIDDLE AGED; PERYLENE; PHLOROGLUCINOL; PHYTOTHERAPY; PLANT EXTRACTS; STATISTICS, NONPARAMETRIC; TERPENES; TREATMENT OUTCOME;

EID: 55249121223     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00663.x     Document Type: Article

References (52)

1. Merskey H, Bogduk N. Classification of chronic pain, 2nd edn. Seattle: International Association for the Study of Pain, 2004.
2. International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004; 24 (Special Issue 1): 8-160.
3. Woda A, Pionchon P. A unified concept of idiopathic orofacial pain: clinical features. J Orofac Pain 1999; 13: 172-84.
4. Woda A, Pionchon P. A unified concept of idiopathic orofacial pain: pathophysiological features. J Orofac Pain 2000; 14: 196-212.
5. Sardella A, Carrassi A. BMS: S for syndrome or S for symptom? A reappraisal of the burning mouth syndrome. Minerva Stomatol 2001; 50: 241-6.
6. Bergdhal M, Bergdhal J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999; 28: 350-4.
7. Zakrzewska JM, Hamlyn PJ. Facial pain. In: Crombie IK, Croft PR, Linton SJ, Le Resche L, Von Korff M, eds. Epidemiology of pain. Seattle: International Association for the Study of Pain Press, 1999; 177-202.
8. Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. JADA 1993; 124: 115-21.
9. Tammiala-Salonen T, Hiidenkari K, Parvinen T. Burning mouth in a Finnish adult population. Community Dent Oral Epidemiol 1993; 21: 67-71.
10. Basker RM, Sturdee DW, Davenport JC. Patients with burning mouths. A clinical investigations of causative factors, including the climacteric and diabetes. Br Dent J 1978; 145: 9-16.
11. Lamey PJ, Allam BF. Vitamin status of patients with burning mouth syndrome and the response to replacement therapy. Br Dent J 1986; 160: 81-4.
12. Forabosco A, Criscuolo M, Coukus G, et al. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 1992; 73: 570-4.
13. Syrjänen S, Piironen P, Yli-Urpo A. salivary content of patients with subjective symptoms resembling galvanic pain. Oral Surg 1984; 58: 387-93.
14. Lamey PJ, Lamb AB. Prospective study of aetiological factors in burning mouth syndrome. Br Med J 1988; 296: 124-36.
15. Samaranayake LP, Lamb AB, Lamey PJ, MacFarlane TW. Oral carriage of Candida species and coliforms in patients with burning mouth syndrome. J Oral Pathol Med 1989; 18: 233-5.
16. Bogetto F, Maina G, Ferro G, Carbone M, Gandolfo S. Psychiatric comorbidity in patients with burning mouth syndrome. Psychosom Med 1998; 60: 378-85.
17. Sardella A, Lodi G, Demarosi F, Uglietti D, Carrassi A. Causative or precipitating aspects of burning mouth syndrome: a case control study. J Oral Pathol Med 2006; 35: 466-71.
18. Zakrzweska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005; 1 (Art No. CD002779).
19. Grushka M, Sessle BJ, Howley TP. Psychophysical assessment of tactile, pain and thermal sensory functions in burning mouth syndrome. Pain 1987; 28: 169-84.
20. Svensson P, Bjerring P, Arendt-Nielsen L, Kaaber S. Sensory and pain thresholds to orofacial argon laser stimulation in patients with chronic burning mouth syndrome. Clin J Pain 1993; 9: 207-15.
21. Jääskeläinen SH, Forssell H, Tenovuo O. Abnormalities in the blink reflex in burning mouth syndrome. Pain 1997; 73: 455-60.
22. Jääskeläinen SH, Forssell H, Tenovuo O. Electrophysiological testing of the trigeminalfacial system: aid in the diagnosis of atypical facial pain. Pain 1999; 80: 191-200.
23. Forssell H, Jääskeläinen SH, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002; 99: 41-7.
24. Ito M, Kurika K, Ito T, Arao M. Pain threshold and pain recovery after experimental stimulation in patients with burning mouth syndrome. Psych Clin Neurosc 2002; 56: 161-8.
25. Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115: 332-7.
26. Femiano F, Scully C. Burning mouth syndrome: double-blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002; 31: 267-9.
27. Gremeau-Richard C, Woda A, Navez ML, et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 2004; 108: 51-7.
28. Albuquerque RJC, de Leeuw R, Carlson CR, Okeson JP, Miller CS, Andersen AH. Cerebral activation during thermal stimulation of patients who have burning mouth disorders: an fMRI study. Pain 2006; 122: 223-34.
29. Fedele S, Fricchione G, Porter SR, Mignogna MD. Burning mouth syndrome (stomatodynia). Q J Med 2007; 8: 527-30.
30. Sardella A, Lodi G, Demarosi F, Bez C, Cassano S, Carrassi A. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis 2006; 12: 152-5.
31. Müller WE. Current St. John's wort research from mode of action to clinical use. A review. Pharmacol Res 2003; 47: 101-9.
32. Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St. John's wort extract in major depression. JAMA 2001; 285: 1978-86.
33. Davidson JRT. Effect of Hypericum perforatum (St. John's wort) in major depressive disorders. A randomized controlled trial. JAMA 2002; 287: 1807-14.
34. Lecrubier Y, Clerc G, Didi R, Kieser M. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatr 2002; 159: 1361-6.
35. Linde K, Mulrow CD, Berner M, Egger M. St John's wort for depression. Cochrane Database Syst Rev 2005; 18: CD000448.
36. Pedersen AML, Smidt D, Nauntofte B, Christiani CJ, Jerlang BB. Burning mouth syndrome: etiopathogenic mechanisms, symptomatology, diagnosis and therapeutic approaches. Oral Biosci Med 2004; 1: 3-19.
37. Costantini M, Musso M, Viterbori P, et al. Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale Support Care. Cancer 1999; 7: 121-7.
38. Bjelland I, Dhal A, Huag T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 2: 69-77.
39. Lamey PJ, Lamb AB. The usefulness of the HAD scale in assessing anxiety and depression in patients with burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1989; 67: 390-2.
40. Madabushi R, Frank B, Drewelow B, Derendorf H, Butterweck V. Hyperforin in St. John's wort drug interactions. Eur J Clin Pharmacol 2006; 62: 225-33.
41. Scott J, Huskisson C. Graphic evaluation of pain. Pain 1976; 2: 175-84.
42. Urquhart J, De Klerk E. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med 1998; 17: 251-67.
43. Moher D, Schulz KF, Altman DG for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 2001; 357: 1191-4.
44. Lawvere S, Mahoney MC. St. John's wort. Am Fam Physician 2005; 72: 2249-54.
45. Bergdhal J, Anneroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med 2002; 24: 213-5.
46. Tammiala-Salonen T, Forssell H. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain 1999; 13: 83-8.
47. Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amilsupiride in burning mouth syndrome: a single-blind study. J Clin Psychiatry 2002; 63: 38-43.
48. Navazesh M, Christensen CM. A comparison of whole mouth resting and salivary measurements procedures. J Dent Res 1982; 61: 1158-82.
49. Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth, 2nd edn Gerodontology 1997; 14: 33-47.
50. Dennis KL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL. Harrison's principles of internal medicine, 16th edn. New York: McGraw-Hill, 2005.
51. Williams D, Lewis MA. Isolation and identification of Candida from the oral cavity. Oral Dis 2000; 38: 11-5.
52. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specification, critique. J Craniomandib Disord Facial Oral Pain 1992; 6: 301-55.